19 min

Trending News – January 27, 2022 Trending Health

    • Management

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: our top headlines from the JP Morgan Healthcare Conference (00:32) and the preliminary national coverage decision for Aduhelm from CMS (14:29).Podcast Tags: healthcare, healthcare news, healthcare workforce, gene therapy, whole person health, Medicare Advantage, CMS, Alzheimer’sSource Links:· https://www.bloomberg.com/news/articles/2022-01-12/rna-is-hot-but-mergers-are-not-at-jpmorgan-healthcare-conference · https://www.modernhealthcare.com/finance/reporters-notebook-jp-morgans-2022-health-conference · https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=Y&NCAId=305 · https://www.kff.org/policy-watch/medicares-coverage-decision-for-the-new-alzheimers-drug-and-why-it-matters/ · https://www.managedhealthcareexecutive.com/view/5-things-you-should-know-about-the-aduhelm-price-cut  For additional discussion, please contact us at TrendingHealth.com (mailto:Hi5@vynamic.com) or share a voicemail at 1-888-VYNAMIC. Mindy McGrath, Healthcare Industry Advisormindy.mcgrath@vynamic.com (mailto:mindy.mcgrath@vynamic.com)Ryan Hummel, Executive and Head of Provider Sectorryan.hummel@vynamic.com (mailto:ryan.hummel@vynamic.com)Jen Burke, Healthcare Industry Strategistjen.burke@vynamic.com (mailto:jen.burke@vynamic.com)

In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: our top headlines from the JP Morgan Healthcare Conference (00:32) and the preliminary national coverage decision for Aduhelm from CMS (14:29).Podcast Tags: healthcare, healthcare news, healthcare workforce, gene therapy, whole person health, Medicare Advantage, CMS, Alzheimer’sSource Links:· https://www.bloomberg.com/news/articles/2022-01-12/rna-is-hot-but-mergers-are-not-at-jpmorgan-healthcare-conference · https://www.modernhealthcare.com/finance/reporters-notebook-jp-morgans-2022-health-conference · https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=Y&NCAId=305 · https://www.kff.org/policy-watch/medicares-coverage-decision-for-the-new-alzheimers-drug-and-why-it-matters/ · https://www.managedhealthcareexecutive.com/view/5-things-you-should-know-about-the-aduhelm-price-cut  For additional discussion, please contact us at TrendingHealth.com (mailto:Hi5@vynamic.com) or share a voicemail at 1-888-VYNAMIC. Mindy McGrath, Healthcare Industry Advisormindy.mcgrath@vynamic.com (mailto:mindy.mcgrath@vynamic.com)Ryan Hummel, Executive and Head of Provider Sectorryan.hummel@vynamic.com (mailto:ryan.hummel@vynamic.com)Jen Burke, Healthcare Industry Strategistjen.burke@vynamic.com (mailto:jen.burke@vynamic.com)

19 min